| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1736-1788, 2018 | 7758 | 2018 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and … JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ... The lancet 392 (10159), 1923-1994, 2018 | 6621* | 2018 |
| Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 M Naghavi, AA Abajobir, C Abbafati, KM Abbas, F Abd-Allah, SF Abera, ... The lancet 390 (10100), 1151-1210, 2017 | 5038 | 2017 |
| Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 MB Reitsma, N Fullman, M Ng, JS Salama, A Abajobir, KH Abate, ... The Lancet 389 (10082), 1885-1906, 2017 | 1985 | 2017 |
| Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of … H Wang, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1084-1150, 2017 | 959 | 2017 |
| Complementary and alternative medicine use in Australia: a national population-based survey CCL Xue, AL Zhang, V Lin, C Da Costa, DF Story The Journal of Alternative and Complementary Medicine 13 (6), 643-650, 2007 | 891 | 2007 |
| Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic … R Lozano, N Fullman, D Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 2091-2138, 2018 | 536 | 2018 |
| Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring SF Zhou, CC Xue, XQ Yu, C Li, G Wang Therapeutic drug monitoring 29 (6), 687-710, 2007 | 464 | 2007 |
| Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development SF Zhou, LL Wang, YM Di, CC Xue, W Duan, CG Li, Y Li Current medicinal chemistry 15 (20), 1981-2039, 2008 | 444 | 2008 |
| Acupuncture for treating fibromyalgia JC Deare, Z Zheng, CCL Xue, JP Liu, J Shang, SW Scott, G Littlejohn Cochrane Database of Systematic Reviews, 2013 | 417 | 2013 |
| Clinical evidence for association of acupuncture and acupressure with improved cancer pain: a systematic review and meta-analysis Y He, X Guo, BH May, AL Zhang, Y Liu, C Lu, JJ Mao, CC Xue, H Zhang JAMA oncology 6 (2), 271-278, 2020 | 375 | 2020 |
| Clinical pharmacogenetics and potential application in personalized medicine SF Zhou, Y Ming Di, E Chan, YM Du, VDW Chow, CC Xue, X Lai, ... Current drug metabolism 9 (8), 738-784, 2008 | 301 | 2008 |
| Polyphenol protection and treatment of hypertension HM Hügel, N Jackson, B May, AL Zhang, CC Xue Phytomedicine 23 (2), 220-231, 2016 | 223 | 2016 |
| Identification of drugs that interact with herbs in drug development SF Zhou, ZW Zhou, CG Li, X Chen, X Yu, CC Xue, A Herington Drug discovery today 12 (15-16), 664-673, 2007 | 219 | 2007 |
| Acupuncture, chiropractic and osteopathy use in Australia: a national population survey CCL Xue, AL Zhang, V Lin, R Myers, B Polus, DF Story BMC public health 8, 1-8, 2008 | 215 | 2008 |
| Panax ginseng in Randomised Controlled Trials: A Systematic Review JL Shergis, AL Zhang, W Zhou, CC Xue Phytotherapy Research 27 (7), 949-965, 2013 | 195 | 2013 |
| Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update SF Zhou, CC Xue, XQ Yu, G Wang Current drug metabolism 8 (6), 526-553, 2007 | 195 | 2007 |
| In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice) XQ Yu, CC Xue, ZW Zhou, CG Li, YM Du, J Liang, SF Zhou Life sciences 82 (1-2), 68-78, 2008 | 184 | 2008 |
| Clinical Drugs that Interact with St. John's Wort and mplication in Drug Development YM Di, CG Li, CC Xue, SF Zhou Current pharmaceutical design 14 (17), 1723-1742, 2008 | 155 | 2008 |
| A Pharmacological Review of Bioactive Constituents of Paeonia lactiflora Pallas and Paeonia veitchii Lynch S Parker, B May, C Zhang, AL Zhang, C Lu, CC Xue Phytotherapy Research 30 (9), 1445-1473, 2016 | 152 | 2016 |
Tony ZhangRMIT University, Melbourne, Australiaยืนยันอีเมลแล้วที่ rmit.edu.au